| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Shuichi Watanabe CEO | OTC PINK Exchange | 58502T107 CUSIP |
| JP Country | 13,024 Employees | 29 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Medipal Holdings Corporation, rooted in its rich history since 1898, stands as a pivotal entity in the pharmaceutical wholesale sector in Japan. Initially known as Mediceo Paltac Holdings Co., Ltd., the company underwent a name change to Medipal Holdings Corporation in October 2009, marking a significant milestone in its evolution. With its headquarters in Tokyo, Japan, Medipal has expanded its reach, catering to a diverse range of healthcare needs. The company's core lies in the prescription pharmaceutical wholesale business, complemented by a broad spectrum of healthcare products and services. These range from diagnostics and testing to treatment and administration solutions, encompassing an extensive variety of medical equipment, materials, and clinical diagnostic reagents right from the pre-symptomatic stage. Medipal's commitment extends beyond mere distribution, delving into PMS services for manufacturers, orphan drug investments, and a multitude of other health-related ventures. This comprehensive approach positions Medipal as a central figure in the healthcare industry, dedicated to fostering well-being across numerous facets of healthcare and related fields.
Medipal excels in the distribution of a wide array of healthcare products. This includes medical equipment and materials vital for diagnostics, testing, treatment, and administration. Additionally, the company distributes clinical diagnostic reagents crucial for the pre-symptomatic stage of diseases, showcasing its comprehensive coverage of healthcare needs.
The company takes on PMS (Post-Marketing Surveillance) services under contract for manufacturers, ensuring the safety and efficacy of pharmaceuticals post-launch. Moreover, Medipal actively invests in orphan drugs, highlighting its commitment to addressing rare diseases and supporting innovative healthcare solutions.
Beyond pharmaceuticals, Medipal's business extends to the wholesale of cosmetics, daily necessities, and OTC (Over-The-Counter) pharmaceuticals, catering to a broader spectrum of consumer health and well-being.
The company also focuses on animal health, offering products for companion animals. This not only includes medications but also encompasses food processing raw materials and livestock feed additives, showing Medipal’s dedication to a comprehensive approach to health that spans both human and animal needs.
Medipal's services further extend into contract-based epidemiological and clinical studies, creation of specialized medical databases, and the operation of class A health dispensing pharmacies. Moreover, it engages in a variety of sectors including life and non-life insurance agency business, cleaning management, distribution center operations, delivery services, and employee dispatch. Their engagement in medical consulting and administrative outsourcing further showcases their versatile approach to healthcare industry needs. Additionally, the company actively participates in the trade of medical clerks and the distribution of specialty pharmaceuticals, alongside providing contract logistics services and information provision services to a diverse clientele that includes hospitals, clinics, drugstores, and various consumer outlets, alongside businesses in the livestock and fishery sectors, and processed food manufacturers.